Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141019 · ClinicalTrials.gov registry record · NA
Trial of Preemptive Pharmacogenetics in Underserved Patients
A NA study of Pharmacogenetic Testing and Use of Prescription Medications, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 492
- Enrollment target
- 1
- Study location
NCT05141019 is a NA study of Pharmacogenetic Testing and Use of Prescription Medications that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 492 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05141019, a NA study of Pharmacogenetic Testing and Use of Prescription Medications, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 492 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed research is relevant to human health because preemptive clinical pharmacogenetic testing may improve the personalization of drug therapy which should improve patient outcomes. Better understanding of the effectiveness and feasibility of preemptive clinical pharmacogenetic testing will inform when and how this innovative healthcare technology is implemented into clinical care. To ensure equitable dissemination in all patient populations, such data is also needed in racial minorities and other traditionally underserved populations. The combined proposed research are relevant to the parts of the NIH's mission pertaining to protecting and improving health and developing scientific human resources that will ensure the Nation's capability to prevent and treat disease.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Panel-based pharmacogenetic genotyping
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 492 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05141019
The ClinicalTrials.gov registry entry for NCT05141019 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pharmacogenetic Testing appearing as the primary indexed condition, and to 1 intervention - of which Panel-based pharmacogenetic genotyping is the first listed.
NCT05141019 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05141019 about?
NCT05141019 is a clinical study titled "Trial of Preemptive Pharmacogenetics in Underserved Patients". This proposed research is relevant to human health because preemptive clinical pharmacogenetic testing may improve the personalization of drug therapy which should improve patient outcomes. Better understanding of the effectiveness and feasibility of preemptive clinical pharmacogenetic testing will ...
What is the current status of trial NCT05141019?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 492 participants. The study started on 2022-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05141019 study?
This clinical trial studies the following conditions: Pharmacogenetic Testing, Use of Prescription Medications.
What interventions are being tested in trial NCT05141019?
The interventions under investigation include: Panel-based pharmacogenetic genotyping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05141019?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05141019 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pharmacogenetic Testing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.